Biomechanical postural disorders: diagnostic approaches and management

Sova S.H.

Main
Publications
Biomechanical postural disorders: diagnostic approaches and management

February 24, 2025

Orthopedics and Traumatology

Sova S.H.

УДК: 616.7:572.511.2

DOI: 10.32471/umj.1680-3051.263234

Keywords :

biomechanical postural disorders,

diagnostics,

management

Specialities :

Orthopedics and Traumatology

Resume

The article is devoted to the polyetiological problem of biomechanical postural disorders, which are characterized by the development of combined multilevel changes in the musculoskeletal system and often transfer such patients to the category of «difficult to treat», thereby prolonging their clinical route to recovery with the chronicity of pain symptoms, disorders of the affective-mental spectrum, as well as the rapid transition of myofascial functional disorders into an organic degenerative-inflammatory process with the subsequent development of various complications in older age. Systematic and comprehensive approaches in the diagnosis and management of biomechanical postural disorders are the key to the patient’s rapid and complete relief from pain, restoration of a high quality of life, professional and social functioning.

References

1. Smit H.J., Strong P. (2020) Structural Elements of the Biomechanical System of Soft Tissue. Cureus, 12(4): e7895. doi: 10.7759/cureus.7895.
2. Bordoni B., Myers T. (2020) A Review of the Theoretical Fascial Models: Biotensegrity, Fascintegrity, and Myofascial Chains. Cureus, 12(2): e7092.
3. Маєрс Т.В. (2024) Анатомічні поїзди: міофасціальні меридіани для мануальних терапевтів і фахівців із відновлення руху. Вид-во «Медицина», 399 с.
4. Nowotny J., Nowotny-Czupryna O., Czupryna K. (2008) Reedukacja Posturalna w Systemie Stacyjnym. Wyd-wo Wyższej Szkoły Administracji w Bielsku-Białej.
5. Blyth F.M., Briggs A.M., Schneider C.H. et al. (2019) The Global Burden of Musculoskeletal Pain-Where to From Here? Am. J. Public Health, 109(1): 35–40.
6. GBD 2021 Other Musculoskeletal Disorders Collaborators (2021) Global, regional, and national burden of other musculoskeletal disorders, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study. Lancet Rheumatol., 5(11): e670–e682.
7. Baranowska A., Sierakowska M., Owczarczuk A. et al. (2023) An Analysis of the Risk Factors for Postural Defects among Early School-Aged Children. J. Clin. Med., 12(14): 4621.
8. Smedbråten K., Grotle M., Jahre H. et al. (2022) Lifestyle behaviour in adolescence and musculoskeletal pain 11 years later: The Trøndelag Health Study. Eur. J. Pain, 26(9): 1910–1922. doi: 10.1002/ejp.2012.
9. Vos T., Allen C., Arora M. et al. (2016) Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: A systematic analysis for the global burden of disease study 2015. Lancet, 388(10053):1545–1602.
10. Khoury A.N., Hatem M., Bowler J., Martin H.D. (2020) Hip-spine syndrome: rationale for ischiofemoral impingement, femoroacetabular impingement and abnormal femoral torsion leading to low back pain. J. Hip. Preserv. Surg., 7(3): 390–400.
11. Nava T. (2019) Physiotherapy rehabilitation in patients with ankylosing spondylitis. Beyond Rheumatol., 1(2): 37–46.
12. Price M.R., Cupler Z.A., Hawk C. et al. (2022) Systematic review of guideline-recommended medications prescribed for treatment of low back pain. Chiropr. Man. Therap., 30(1): 26. doi: 10.1186/s12998-022-00435-3.
13. Fathi M., Zare M.A., Bahmani H.R., Zehtabchi S. (2015) Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. Am. J. Emerg. Med., 33(9): 1205–1208.
14. Friedman B.W., Dym A.A., Davitt M. (2015) Naproxen With Cyclobenzaprine, Oxycodone/Acetaminophen, or Placebo for Treating Acute Low Back Pain: A Randomized Clinical Trial. JAMA, 314(15): 1572–1580. doi.org/10.1001/jama.2015.13043.
15. Moore R.A., Derry Sh., Aldington D., Wiffen Ph.J. (2015) Single dose oral analgesics for acute postoperative pain in adults – an overview of Cochrane reviews. Cochrane Database Syst. Rev., 2015(9): CD008659. doi: 10.1002/14651858.CD008659.pub3.
16. Reginster J.Y., Malmstrom K., Mehta A. (2007) Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis. Ann. Rheum. Dis., 66(7): 945–951.
17. Trelle S., Reichenbach S., Wandel S. et al. (2011) Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ, 342: 7086.
18. Varas-Lorenzo C., Riera-Guardia N., Calingaert B. et al. (2013) Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies. Pharmacoepidemiology and Drug Safety, 22(6): 559–570.
19. Sanchez-Matienzo D., Arana A., Castellsague J., Perez-Gutthann S. (2006) Hepatic disorders in patients treated with COX-2 selective inhibitors or nonselective NSAIDs: a case / noncase analysis of spontaneous reports. Clin. Ther., 28(8): 1123–1132.
20. Meunier L., Larrey D. (2018) Recent advances in hepatotoxicity of non-steroidal anti-inflammatory drugs. Ann. Hepatol., 17: 187–191.